Hvivo Share Discussion Threads

[chica1] 17/1/2023 09:43

I'll help you out Yump..some of these guys have pea brains.I wonder if said person has the common decency to apologise.




Thu Feb 15 2018 - 17:56

The drug-development group Venn Life Sciences says its earnings have improved despite a fall in revenue. The Irish company, which is listed on the junior markets in Dublin and London, has refocused its strategy in the past year.

In a trading update, Venn said revenue fell from €18.2 million to €17.8 million but earnings before interest, tax, depreciation and amortisation were up from 2016’s €400,000; it didn’t provide a specific figure. “Given the headwind from project deferrals announced at the half year, the board believes that this outcome reflects solid progress in the business,” the company said in a statement.

[chica1] 17/1/2023 09:38

Love to see a 7.6 million trade over here

[inaminute] 17/1/2023 09:37

No idea why on positive days oxygen is given to the halfwits. Almost as if the responders are in bed with them?

[troutisout] 17/1/2023 09:31

Go on then, you seem to want to spend time on this thread, so go and have a look and give us the link, you have already changed the figure from £15m to £12m perhaps you need to check things yourself before making such statements. Just saying....

[yump] 17/1/2023 09:25

Actually Venn’s revenue was more like £12mln before ORPH reversed in.

Easy to find if you look.

[troutisout] 17/1/2023 09:24

Did someone really sell 100k at 15.22p just then or fat finger?
Nice big trade just before....

[troutisout] 17/1/2023 09:22

Venn get contracts each year, most are not RNSed, I would like to see you provide some links to the £15m turnover including what profit (loss) was made on that revenue.

[baldrick1] 17/1/2023 09:21

Rns soon ..perhaps of new institutional holdings imo..

[yump] 17/1/2023 09:17

First time I remember Venn getting anything while within HVO. Pretty sure their turnover used to be around £15mln.

I see the sheep are selling on the previous high, reinforcing the self-fulfilling charts.

[qackers] 17/1/2023 09:01

Nice message when a 3.2m euro contract is not deemed worthy of a full RNS.

[mikeh30] 17/1/2023 08:47

Be happy no gap to come back to when higher up

[troutisout] 17/1/2023 08:34

All changed and they have moved the spread to where it should be, however as I said it isn't as lop-sided as it seems on the trade data.

[troutisout] 17/1/2023 08:32

Strangely, I am getting quotes to buy at 16p which is the quoted bid, how many of the trades at 16p are actually buys??

[sos100] 17/1/2023 07:39

can we push to 20p..

[inaminute] 17/1/2023 07:36

Furthers our one-stop shop credentials

[mark10101] 17/1/2023 07:19

That is a very chunky win for Venn.

[parob] 17/1/2023 07:17

A very nice €3.2M contract win starting this month.Trading update coming up next week too. Let's see if we get an "ahead of expectations" statement when it arrives on the 26th, together with analysts upgrades too.

[chica1] 16/1/2023 17:30

If we could get this up to 50p we'll probably be best buds😝㈶1;

I still think Hvivo is intrinsically undervalued considering the space its in.
£350 million valuation is not absurd imho but 2023 probably needs to be a bumper year

[yump] 16/1/2023 16:59

chica1

Good grief that's 2 things in the last few weeks we agree on !

[yump] 16/1/2023 16:58

Inaminute

I wasn't referring to Hvivo - it was a general point.
I said 'a business' not 'this business'.

This isn't a football match is it ?

Try not to put anyone in the 'opponents' camp before you reach a conclusion - it will distort your views completely.

[chica1] 16/1/2023 16:55

Nice to see big trades going thru..
Although I thought we'd fight harder to break 15.8p

Did m5 put the hex on it again 😳

[baldrick1] 16/1/2023 15:36

Instant traders are getting caught out..

[chica1] 16/1/2023 15:30

Pro trader..very few original investors made money on Amryt.It was basically a wash!
Most of the market cap was 2 acquisitions Aegerion+debt and Chiasma.
And FYI the 3 companies acquired to create the original Amryt, 2 never produced at thing and the 3rd had a lotion (episalvan/Filsuvez)for partial thickness wounds which they spent a fortune on barely got approval the EMA and failed FDA approval for Epidermolysis Bullosa.

It's very bad lazy journalism!

[baldrick1] 16/1/2023 14:52

54 million pounds expected sales for 2023 with 95% already cntracted..aiming to grow sales to 80-100 million pounds up to the end of 2024

[inaminute] 16/1/2023 14:22

Couple of million in sales. Great demonstration of just what a muppet you are. Back on ignore